Categories AlphaGraphs, Earnings, Health Care

Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates

Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%.

Trxade Q4 2021 earnings infographic

Fourth-quarter revenues increased 19.7% year-over-year to $2.4 million and came in above analysts’ estimates. The company added 175 registered members during the three-month period.

Trxade reported a net loss of $0.8 million or $0.10 per share for the fourth quarter, which marked an improvement from the $2.3 million or $0.29 per share loss reported in the year-ago quarter. The bottom line also beat analysts’ estimates.

Check this space to read management/analysts’ comments on Trxade’s Q4 2021 results

Shares of Trxade closed Monday’s trading higher and continued to gain in the extended session, soon after the earnings announcement. The stock has lost about 55% in the past six months.

Prior Performance

  • Trxade Health Q3 2021 earnings
  • Trxade Health Q2 2021 earnings
  • Trxade Q1 2021 earnings
  • Trxade Q4 2020 earnings

Most Popular

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and

AMAT Stock: Is now the right time to invest in Applied Materials?

It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied

Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year

Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the

Add Comment
Viewing Highlight